Clinical trial
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed…
NCT00006326 · Agouron Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00006326 |
|---|---|
| Title | Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir |
| Official title | A Randomized, Open-Label Study to Evaluate 3 Salvage Regimens in HIV-Infected Subjects Experiencing Virologic Failure on an Initial HAART Regimen Containing Nelfinavir |
| Lead sponsor | Agouron Pharmaceuticals, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Ritonavir, Delavirdine mesylate |
| Enrollment | 60 |
| Start date | Aug 1, 2000 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: